JP2024525815A5 - - Google Patents
Info
- Publication number
- JP2024525815A5 JP2024525815A5 JP2024502111A JP2024502111A JP2024525815A5 JP 2024525815 A5 JP2024525815 A5 JP 2024525815A5 JP 2024502111 A JP2024502111 A JP 2024502111A JP 2024502111 A JP2024502111 A JP 2024502111A JP 2024525815 A5 JP2024525815 A5 JP 2024525815A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- cells
- nucleic acids
- cell receptor
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163222130P | 2021-07-15 | 2021-07-15 | |
| US63/222,130 | 2021-07-15 | ||
| US202263300905P | 2022-01-19 | 2022-01-19 | |
| US63/300,905 | 2022-01-19 | ||
| US202263344221P | 2022-05-20 | 2022-05-20 | |
| US63/344,221 | 2022-05-20 | ||
| PCT/US2022/036841 WO2023287803A2 (en) | 2021-07-15 | 2022-07-12 | Compositions and methods for making novel t-cell receptors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024525815A JP2024525815A (ja) | 2024-07-12 |
| JP2024525815A5 true JP2024525815A5 (https=) | 2025-06-16 |
Family
ID=84919648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024502111A Pending JP2024525815A (ja) | 2021-07-15 | 2022-07-12 | 新規のｔ細胞受容体を作製するための組成物および方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US12606936B2 (https=) |
| EP (1) | EP4370542A4 (https=) |
| JP (1) | JP2024525815A (https=) |
| WO (1) | WO2023287803A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4281569A4 (en) * | 2021-01-25 | 2025-04-02 | The Regents Of The University Of California | Methods and compositions for labeling and selecting antigen-specific T cells |
| WO2025019682A1 (en) * | 2023-07-18 | 2025-01-23 | Heligenics Inc. | Method for producing and screening multi-functional chimeric biologic libraries |
| WO2025032194A1 (en) * | 2023-08-08 | 2025-02-13 | Ospedale San Raffaele S.R.L. | T-cell receptors |
| CN117338914B (zh) * | 2023-10-27 | 2024-09-06 | 中山市珈钰生物医药有限公司 | 一种同种异体树突细胞肿瘤疫苗及其制备方法和应用 |
| WO2025160372A1 (en) * | 2024-01-24 | 2025-07-31 | Hifibio Sas | Methods for identification of cognate pairs of ligands and receptors |
| WO2026043868A1 (en) * | 2024-08-20 | 2026-02-26 | Amgen Inc. | A cell-based platform for identifying native protein-protein interactions in mammalian display libraries |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2771336C (en) | 2009-09-15 | 2019-11-26 | The Board Of Trustees Of The Leland Stanford Junior University | Synergistic anti-cd47 therapy for hematologic cancers |
| MX2018003534A (es) * | 2015-09-25 | 2019-04-25 | Abvitro Llc | Proceso de alto rendimiento para identificacion de blanco de receptor de celula t de secuencias de receptor de celula t apareadas de manera natural. |
| EP3202783A1 (en) | 2016-02-02 | 2017-08-09 | Ecole Polytechnique Fédérale de Lausanne (EPFL) | Engineered antigen presenting cells and uses thereof |
| WO2019077062A1 (en) | 2017-10-18 | 2019-04-25 | Vivia Biotech, S.L. | C-CELLS ACTIVATED BY BIT |
| JP7658584B2 (ja) * | 2019-05-23 | 2025-04-08 | マサチューセッツ インスティテュート オブ テクノロジー | リガンドの発見およびレトロウイルス表面ディスプレーを介した遺伝子送達 |
-
2022
- 2022-07-12 US US17/863,200 patent/US12606936B2/en active Active
- 2022-07-12 EP EP22842767.0A patent/EP4370542A4/en active Pending
- 2022-07-12 WO PCT/US2022/036841 patent/WO2023287803A2/en not_active Ceased
- 2022-07-12 JP JP2024502111A patent/JP2024525815A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024525815A5 (https=) | ||
| JP2024507996A5 (https=) | ||
| US10780118B2 (en) | Method and compositions for cellular immunotherapy | |
| US12606936B2 (en) | Compositions and methods for making novel T-cell receptors | |
| US12076343B2 (en) | Engineered safety in cell therapy | |
| EP3700926A1 (en) | Methods of making chimeric antigen receptor-expressing cells | |
| CN106536558A (zh) | 转基因遗传标签和使用的方法 | |
| JP2021532742A5 (https=) | ||
| JP2025511151A5 (https=) | ||
| US12152251B2 (en) | T cells with improved functionality | |
| CN110511912A (zh) | 免疫细胞的功能调节 | |
| CA3229746A1 (en) | Methods of making chimeric antigen receptor-expressing cells | |
| CN117683139A (zh) | 组成型嵌合细胞因子受体及表达其的免疫细胞及应用 | |
| JP2025518033A (ja) | 免疫細胞クリスパースクリーニングのための方法及び組成物 | |
| CN115724996A (zh) | 含有膜表面结构域的多肽及其用途 | |
| EP4210733B1 (en) | System for inducible expression of an adapter in immune cells | |
| WO2023164688A1 (en) | Allogeneic therapeutic cells | |
| WO2023242434A1 (en) | Modified immune cells | |
| CN112251452A (zh) | Til/tcr-t细胞治疗平台 | |
| WO2026016944A1 (zh) | 腺病毒载体及其应用 | |
| KR20250013199A (ko) | 세포 요법 작제물의 비-바이러스 전달 | |
| CN120988141A (zh) | 一种过表达cd2的双靶向嵌合抗原受体及其应用 | |
| US20240366670A1 (en) | Allogenic therapeutic cells with reduced risk of immune rejection | |
| EA050762B1 (ru) | Аллогенные терапевтические клетки | |
| JP2025526409A (ja) | 細胞療法を補完するための導入遺伝子をコードするウイルス |